Dr. Stéphane Temam is an otolaryngologist, head and neck surgeon, and chief of the Head and Neck Oncology Department. 

His area of expertise is the comprehensive, multidisciplinary care—from diagnosis to treatment, particularly surgical treatment—of adult and pediatric patients with benign or malignant ENT tumors of the head and neck (carcinoma or sarcoma), specifically those of the oral cavity (tongue, mandible, etc.), the oropharynx (tonsils, base of the tongue, etc.), the larynx (vocal cords, etc.), the hypopharynx (piriform sinus, esophagus, etc.), the facial skeleton (nose, nasal cavity, ethmoid, maxillary, and sphenoid sinuses, skull base, orbit, pterygo-maxillary and infratemporal fossae), the nasopharynx (cavum), the salivary glands (parotid, submandibular gland, etc.) in both initial and recurrent cases. He is a nationally and internationally recognized expert in the field of head and neck cancers

His research has focused on head and neck oncology, encompassing oncological surgery, translational research, the epidemiology of HPV-related cancers, predictive biomarkers, advanced imaging, and the development of new therapeutic strategies. More recently, his involvement in international multicenter clinical trials has focused on perioperative immunotherapy and innovative treatments for squamous cell carcinomas of the head and neck, contributing to the emergence of new therapeutic standards. At the same time, his work has contributed to the improvement of surgical resection and reconstruction techniques, as well as to a better understanding of prognostic and predictive factors in ENT cancers.

In addition to his medical degree with a specialty in ENT, he also holds a Doctor of Philosophy (PhD) from Paris-Saclay University and university diplomas (DU) in cervicofacial oncology, a European University Diploma (DUERCC) in Clinical Cancer Research, and a University Diploma (DU) in Clinical Oncology.

Dr. Temam serves as coordinator for several clinical research studies in head and neck oncology for the ENT committee at Gustave Roussy; he is the author of more than 200 scientific publications and coordinates various training and educational programs. He has chaired the French Head and Neck Tumor Study Group (GETTEC) and is a member of the Head and Neck Radiation Oncology Group (GORTEC), the French Society of Cervicofacial Oncology (SFCCF), and the French Society of ENT and Head and Neck Surgery (SFORL).

He is the author of numerous scientific publications.